Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 3:46 AM
Ignite Modification Date: 2025-12-26 @ 2:33 AM
NCT ID: NCT00564902
Description: Lutein and Zeaxanthin have been used as ingredients in dietary supplements since 1994. No adverse report has ever been filed
Frequency Threshold: 3
Time Frame: 12 months
Study: NCT00564902
Study Brief: The Zeaxanthin and Visual Function Study
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Lutein Lutein 9 mg per day None None 0 10 0 10 View
Lutein Zeaxanthin 3R 3'R Zeaxanthin 8 mg, Lutein 8 mg per day during 12 months None None 0 25 0 25 View
Zeaxanthin 3R 3'R Zeaxanthin 8 mg per day during 12 months None None 0 25 0 25 View
Serious Events(If Any):
Other Events(If Any):